News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Intensive testosterone-blocking therapy delays prostate-specific antigen progression in BRPC
31 Jan 2024
byJairia Dela Cruz
A 52-week course of intensified androgen-deprivation therapy (ADT) appears to extend prostate-specific antigen progression-free survival (PSA-PFS) in patients with biochemically recurrent prostate cancer (BRPC) compared with ADT alone, without prolonging time to testosterone recovery, according to the phase III open-label PRESTO trial.
31 Jan 2024

Aqueous shunts with extraocular reservoir lower IOP in adults with OAG
31 Jan 2024
Adults with open-angle glaucoma (OAG) may benefit from the implantation of aqueous shunts with extraocular reservoir, including valved or nonvalved devices, which can reduce intraocular pressure (IOP), as shown in a study.
31 Jan 2024






